ACTIVE

HEALTH & TECHNOLOGY

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-1,4 k €+67,2 %over 1 year
Gross margin-349,8 €+84,7 %over 1 year
Equity-60,2 k €-2,4 %over 1 year

Identity

Source · BCE/KBO

HEALTH & TECHNOLOGY is a Private limited company incorporated in 2015. Its registered office is in Uccle.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0644.531.049
Incorporation
15/12/2015
Legal form
Private limited company
Registered office
Avenue Brugmann 319
1180 Uccle · BruxellesSee on map
Contributed capital
100 000,00 €
Latest accounts
31/12/2025

Financials

Source · NBB, 10 filings

Trend over 10 financial years

20252024202320222021
Income statement
Gross margin-349,8 €-2,3 k €-1,8 k €-1,5 k €-1,3 k €
EBITDA-349,8 €-2,7 k €-2,1 k €-1,9 k €-1,6 k €
Operating result-349,8 €-2,7 k €-2,1 k €-1,9 k €-17,8 k €
Net result-1,4 k €-4,3 k €-3,8 k €-2,9 k €-18,7 k €
Balance sheet
Equity-60,2 k €-58,8 k €-54,4 k €-50,6 k €-47,7 k €
Total assets1,4 k €1,4 k €409,4 €1 k €3 k €
Cash1,4 k €1,4 k €76,7 €712,6 €2,7 k €
Debts61,6 k €60,2 k €54,9 k €51,7 k €50,8 k €

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 4 ended

Active mandates

Jean-Charles FIGONI

Managing director

Active
Jérôme, Guibert, Jacques DE MEEÛS D'ARGENTEUIL

Director

Active
Miriam TAUB

Director

Active
Noémi DE BRABANT

Managing director

Active

Ended mandates

JEAN-CHARLES FIGONI

Director · since 20 mars 2024

Ended
Bernard DELVENNE

Manager · since 15 décembre 2015

Ended
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE

Director · 0403.057.962

Represented by Bertrand BUSSY

Ended
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE

Manager · 0403.057.962

Represented by Bertrand BUSSY

Ended

Other companies at this address

Avenue Brugmann 319 1180 Uccle
CompanyCBE no.
Association des Copropriétaires à Uccle, avenue Brugmann 319● Active
0548.825.208
Jewish Partnership for Europe● Active
0466.159.036
RSight● Active
1035.861.218
S 2 M● Active
0807.153.133
Serenia● Active
1029.137.336

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/08/202631/08/202516/08/202431/07/202328/07/202213/07/2021
General meeting19/05/202630/08/202521/05/202416/05/202317/05/202218/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202519/05/202631/08/2026FrenchPDF
Micro model31/12/202430/08/202531/08/2025FrenchPDF
Micro model31/12/202321/05/202416/08/2024FrenchPDF
Micro model31/12/202216/05/202331/07/2023FrenchPDF
Abridged model31/12/202117/05/202228/07/2022FrenchPDF
Abridged model31/12/202018/05/202113/07/2021FrenchPDF
Abridged model31/12/201919/05/202007/07/2020FrenchPDF
Abridged model31/12/201821/05/201931/07/2019FrenchPDF
Micro model31/12/201725/06/201831/08/2018FrenchPDF
Abridged model31/12/201616/05/201710/08/2017FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 4 ended

Active mandates

Jean-Charles FIGONI

Managing director

Active
Jérôme, Guibert, Jacques DE MEEÛS D'ARGENTEUIL

Director

Active
Miriam TAUB

Director

Active
Noémi DE BRABANT

Managing director

Active

Ended mandates

JEAN-CHARLES FIGONI

Director · since 20 mars 2024

Ended
Bernard DELVENNE

Manager · since 15 décembre 2015

Ended
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE

Director · 0403.057.962

Represented by Bertrand BUSSY

Ended
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE

Manager · 0403.057.962

Represented by Bertrand BUSSY

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates25/06/2026
    MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/04/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/09/2018
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Other17/12/2015
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,4 k €↑
  2. 2025
    Name changeHealth & Technology
  3. 2024
    Annual accounts 2024-4,3 k €↓
  4. 2023
    Annual accounts 2023-3,8 k €↓
  5. 2022
    Annual accounts 2022-2,9 k €↑
  6. 2021
    Annual accounts 2021-18,7 k €↑
  7. 2021
    Name changeHEALTH AND TECHNOLOGY
  8. 2020
    Annual accounts 2020-50,2 k €↑
  9. 2019
    Annual accounts 2019-52,8 k €↓
  10. 2018
    Annual accounts 2018-30,2 k €↓
  11. 2017
    Annual accounts 20175,1 k €↑
  12. 2016
    Annual accounts 2016-865,3 €
  13. 15/12/2015
    IncorporationPrivate limited company